Re: TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating MicroRNA miR-200c

European Urology

Volumn 65, Issue 5, 2014, Pages 1011-

  Culig, Zoran ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 200C; TRANSCRIPTION FACTOR ZEB1; MICRORNA; ONCOPROTEIN;

CANCER CHEMOTHERAPY; CARCINOGENESIS; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; ERG OGENE; GENE EXPRESSION; GENE FUSION; GENE OVEREXPRESSION; NOTE; ONCOGENE; PRIORITY JOURNAL; PROSTATE CANCER; TRANSMEMBRANE PROTEASE SERINE 2 GENE; TUMOR INVASION; UPREGULATION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR;

HUMANS; MALE; MICRORNAS; ONCOGENE PROTEINS, FUSION; PROSTATIC NEOPLASMS;

EID: 84896355044     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.12.038     Document Type: Note

References (4)

1. F. Demichelis, K. Fall, and S. Perner et al. TMPRSS:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort Oncogene 26 2007 4596 4599
2. A.B. Rajput, M.A. Miller, and A. De Luca et al. Frequency of the TMPRSS:ERG gene fusion is increased in moderate to poorly differentiated prostate cancer J Clin Pathol 60 2007 238 243
3. B.S. Carver, J. Tran, and A. Gopalan et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate Nat Genet 41 2009 619 624
4. M. Puhr, J. Hoefer, and G. Schäfer et al. Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression miR-200c and miR-205 Am J Pathol 181 2012 2188 2201